Cox Christopher Nixon
SEC insider (Form 3/4/5 filer). CIK 0002008212. Director at Newsmax Inc. (NMAX) and 2 other issuers. 6 reported Form 4/5 transactions since Sep 2024; latest on May 20, 2026. Located in MOUNTAIN VIEW, CA.
Companies Cox Christopher Nixon has filed insider reports for
- Newsmax Inc. (NMAX): Director
- Alto Neuroscience, Inc. (ANRO): Director
- High-Trend International Group (HTCO): Director
Cox Christopher Nixon
CIK: 0002008212
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- May 20, 2026NMAX
Newsmax Inc.
AwardDirectOption (Right to Buy)
23.9K shares- - May 12, 2026ANRO
Alto Neuroscience, Inc.
AwardDirectStock Option (right to buy)
11K shares- - Jan 2, 2026ANRO
Alto Neuroscience, Inc.
AwardDirectStock Option (right to buy)
7.2K shares at avg. $11.82- - May 13, 2025ANRO
Alto Neuroscience, Inc.
AwardDirectStock Option (right to buy)
15.3K shares- - Mar 28, 2025NMAX
Newsmax Inc.
AwardDirectOption (Right to Buy)
17.5K shares- - Jan 2, 2025ANRO
Alto Neuroscience, Inc.
AwardDirectStock Option (right to buy)
25.2K shares at avg. $3.17-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 20, 2026 |  NMAX Newsmax Inc. | Award Option (Right to Buy) | 23,940 | - | - | Direct |
| May 12, 2026 |  ANRO Alto Neuroscience, Inc. | Award Stock Option (right to buy) | 10,958 | - | - | Direct |
| Jan 2, 2026 | ANRO Alto Neuroscience, Inc. | Award Stock Option (right to buy) | 7,189 | $11.82 | - | Direct |
| May 13, 2025 | ANRO Alto Neuroscience, Inc. | Award Stock Option (right to buy) | 15,287 | - | - | Direct |
| Mar 28, 2025 | NMAX Newsmax Inc. | Award Option (Right to Buy) | 17,500 | - | - | Direct |
| Jan 2, 2025 | ANRO Alto Neuroscience, Inc. | Award Stock Option (right to buy) | 25,236 | $3.17 | - | Direct |
1-6 of 6 transactions